-
公开(公告)号:US20080015179A1
公开(公告)日:2008-01-17
申请号:US11644124
申请日:2006-12-22
申请人: Lewis Makings , Miguel Blanco , Dennis Hurley , Ioana Drutu , Gabriel Raffai , Daniele Bergeron , Akiko Nakatani , Andreas Termin , Alina Silina
发明人: Lewis Makings , Miguel Blanco , Dennis Hurley , Ioana Drutu , Gabriel Raffai , Daniele Bergeron , Akiko Nakatani , Andreas Termin , Alina Silina
IPC分类号: A61K31/438 , A61K31/497 , A61K31/55 , A61P25/00 , C07D487/00 , C07D487/10 , C07D491/107 , C07D495/04
CPC分类号: A61K31/4545 , A61K31/438 , A61K31/46 , A61K31/497 , A61K31/498 , A61K31/501 , A61K31/506 , C07D221/20 , C07D401/04 , C07D401/06 , C07D405/04 , C07D417/14 , C07D471/10 , C07D487/08 , C07D491/10
摘要: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.
-
公开(公告)号:US20070043023A1
公开(公告)日:2007-02-22
申请号:US11359960
申请日:2006-02-22
申请人: Lewis Makings , Miguel Blanco , Dennis Hurley , Ioana Drutu , Gabriel Raffai , Daniele Bergeron , Akiko Nakatani , Andreas Termin , Alina Silina
发明人: Lewis Makings , Miguel Blanco , Dennis Hurley , Ioana Drutu , Gabriel Raffai , Daniele Bergeron , Akiko Nakatani , Andreas Termin , Alina Silina
IPC分类号: A61K31/55 , A61K31/4747
CPC分类号: A61K31/4747 , A61K31/435 , A61K31/438 , A61K31/55 , C07D221/20 , C07D223/32 , C07D405/06 , C07D451/02 , C07D471/10 , C07D491/10
摘要: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.
-
公开(公告)号:US20060079505A1
公开(公告)日:2006-04-13
申请号:US11208386
申请日:2005-08-19
申请人: Lewis Makings , Miguel Blanco , Dennis Hurley , Ioana Drutu , Gabriel Raffai , Daniele Bergeron , Akiko Nakatani , Andreas Termin , Alina Silina
发明人: Lewis Makings , Miguel Blanco , Dennis Hurley , Ioana Drutu , Gabriel Raffai , Daniele Bergeron , Akiko Nakatani , Andreas Termin , Alina Silina
IPC分类号: A61K31/55 , A61K31/4747 , C07D225/04 , C07D223/14
CPC分类号: C07D401/06 , A61K31/435 , A61K31/438 , A61K31/4747 , A61K31/55 , C07D221/20 , C07D223/32 , C07D405/04 , C07D405/06 , C07D405/12 , C07D451/02 , C07D451/04 , C07D471/10 , C07D491/10
摘要: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.
-
公开(公告)号:US20060019962A1
公开(公告)日:2006-01-26
申请号:US11140808
申请日:2005-05-31
IPC分类号: A61K31/506 , A61K31/497 , A61K31/496 , C07D403/02 , C07D403/14
CPC分类号: C07D213/74 , C07D213/82 , C07D213/85 , C07D237/24 , C07D239/42 , C07D241/20 , C07D241/24 , C07D401/04 , C07D451/04
摘要: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.
-
公开(公告)号:US20050171141A1
公开(公告)日:2005-08-04
申请号:US11005944
申请日:2004-12-07
IPC分类号: A61K31/4745 , C07D471/02 , C07D471/04
CPC分类号: C07D471/04
摘要: The modulator compounds described herein modulate muscarinic receptors and are useful for treating muscarinic receptor mediated diseases.
摘要翻译: 本文所述的调节剂化合物调节毒蕈碱受体并且可用于治疗毒蕈碱受体介导的疾病。
-
公开(公告)号:US08153828B2
公开(公告)日:2012-04-10
申请号:US12499047
申请日:2009-07-07
申请人: Lewis Makings , Gregor Zlokarnik
发明人: Lewis Makings , Gregor Zlokarnik
IPC分类号: C07D311/06
CPC分类号: C07D493/10 , C07D219/06 , C07D265/38 , C07D311/16 , C07D311/82 , C12Q1/26 , G01N2333/90245 , G01N2500/02 , Y10S435/968
摘要: The invention provides a compound, useful as an optical probe or sensor of the activity of at least one cytochrome P450 enzyme, and methods of using the compound to screen candidate drugs, and candidate drugs identified by these methods. The optical probe of the invention is a compound having the generic structure Y-L-Q, wherein Q is a chemical moiety that gives rise to optical properties in its hydroxy or hyrdoxylate, phenol or phenoxide form that are different from the optical properties that arise from its ether form.
摘要翻译: 本发明提供了可用作至少一种细胞色素P450酶的活性的光学探针或传感器的化合物,以及使用该化合物筛选候选药物的方法以及通过这些方法鉴定的候选药物。 本发明的光学探针是具有一般结构YLQ的化合物,其中Q是一种化学部分,其产生与其醚形式产生的光学性质不同的羟基或羟乙酸酯,苯酚或酚盐形式的光学性质 。
-
公开(公告)号:US20060287303A1
公开(公告)日:2006-12-21
申请号:US11288938
申请日:2005-11-29
申请人: Dennis Hurley , Daniele Bergeron , Ioana Drutu , Miguel Blanco , Lewis Makings , Akiko Nakatani , Gabriel Raffai , Alina Silina
发明人: Dennis Hurley , Daniele Bergeron , Ioana Drutu , Miguel Blanco , Lewis Makings , Akiko Nakatani , Gabriel Raffai , Alina Silina
IPC分类号: A61K31/541 , A61K31/5377 , A61K31/496 , A61K31/454 , A61K31/453 , A61K31/452 , C07D417/02 , C07D403/02 , C07D413/02
CPC分类号: C07D211/10 , A61K31/4439 , C07D211/18 , C07D211/32 , C07D211/34 , C07D211/38 , C07D211/42 , C07D211/52 , C07D211/64 , C07D401/04 , C07D401/06 , C07D401/10 , C07D405/04 , C07D405/06 , C07D405/10 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/10 , C07D417/10 , C07D417/12 , C07D451/02 , C07D493/08
摘要: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.
-
公开(公告)号:US20070054911A1
公开(公告)日:2007-03-08
申请号:US11390748
申请日:2006-03-28
申请人: Ioana Drutu , Miguel Blanco , Lewis Makings , Gabriel Raffai , Valentin Zunic
发明人: Ioana Drutu , Miguel Blanco , Lewis Makings , Gabriel Raffai , Valentin Zunic
IPC分类号: A61K31/52 , A61K31/53 , A61K31/502 , A61K31/501 , A61K31/498 , A61K31/497 , A61K31/4545 , A61K31/4709 , A61K31/454 , A61K31/453
CPC分类号: C07D211/58 , A61K31/4468 , A61K31/453 , A61K31/454 , A61K31/4545 , A61K31/46 , A61K31/4709 , A61K31/497 , A61K31/498 , A61K31/501 , A61K31/502 , A61K31/52 , A61K31/53 , C07D451/04 , C07D519/00
摘要: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.
摘要翻译: 本发明涉及毒蕈碱受体的调节剂。 本发明还提供包含这种调节剂的组合物,及其用于治疗毒蕈碱受体介导的疾病的方法。
-
公开(公告)号:US20050113423A1
公开(公告)日:2005-05-26
申请号:US10800022
申请日:2004-03-12
申请人: Frederick VanGoor , Sara Ruah , Ashvani Singh , Eric Olson , Lewis Makings , Jesus Gonzalez , James Rader , Fred Chambers , Mark Miller , Peter Grootenhuis , Yahua Liu
发明人: Frederick VanGoor , Sara Ruah , Ashvani Singh , Eric Olson , Lewis Makings , Jesus Gonzalez , James Rader , Fred Chambers , Mark Miller , Peter Grootenhuis , Yahua Liu
IPC分类号: A61P37/00 , C07D231/12 , C07D231/16 , C07D401/04 , C07D401/10 , C07D403/10 , C07D405/04 , C07D409/04 , C07D413/04 , C07D417/14 , A61K31/4162 , A61K31/415 , A61K31/4439
CPC分类号: C07D231/12 , C07D231/16 , C07D401/04 , C07D401/10 , C07D403/10 , C07D405/04 , C07D409/04 , C07D413/04 , C07D417/14
摘要: The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
摘要翻译: 本发明涉及ATP结合盒(“ABC”)转运体或其片段的调节剂,包括囊性纤维化跨膜调节剂(“CFTR”),其组合物及其方法。 本发明还涉及使用这种调节剂治疗ABC转运蛋白介导的疾病的方法。
-
公开(公告)号:US20070072256A1
公开(公告)日:2007-03-29
申请号:US11531136
申请日:2006-09-12
申请人: Lewis MAKINGS , Gregor ZLOKARNIK
发明人: Lewis MAKINGS , Gregor ZLOKARNIK
IPC分类号: C12Q1/26
CPC分类号: C07D493/10 , C07D265/38 , C07D311/16 , C07D311/82 , C12Q1/26 , G01N2333/90245 , G01N2500/02
摘要: The invention provides a compound, useful as an optical probe or sensor of the activity of at least one cytochrome P450 enzyme, and methods of using the compound to screen candidate drugs, and candidate drugs identified by these methods. The optical probe of the invention is a compound having the generic structure Y-L-Q, wherein Y is selected from the group consisting of Q as herein defined, saturated C1-C20 alkyl, unsaturated C1-C20 alkenyl, unsaturated C1-C20 alkynyl, substituted saturated C1-C20 alkyl, substituted unsaturated C1-C20 alkenyl, substituted unsaturated C1-C20 alkynyl, C1-C20 cycloalkyl, C1-C20 cycloalkenyl, substituted saturated C1-C20 cycloalkyl, substituted unsaturated C1-C20 cycloalkenyl, aryl, substituted aryl, heteroaryl and substituted heteroaryl; L is selected from the group of (—OCR2H)p—, wherein for each p, all R2 are separately selected from the group consisting of a hydrogen atom, saturated C1-C20 alkyl, unsaturated C1-C20 alkenyl, unsaturated C1-C20 alkynyl, substituted saturated C1-C20 alkyl, substituted unsaturated C1-C20 alkenyl, substituted unsaturated C1-C20 alkynyl, C1-C20 cycloalkyl, C1-C20 cycloalkenyl, substituted saturated C1-C20 cycloalkyl, substituted unsaturated C1-C20 cycloalkenyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, and p is a positive integer no greater than twelve; and Q is a chemical moiety that gives rise to optical properties in its hydroxy or hydroxylate, phenol or phenoxide form that are different from the optical properties that arise from its ether form. Most preferably, p is one, R2 is hydrogen, and Q is the ether form of a phenoxide fluorophore.
-
-
-
-
-
-
-
-
-